Hemophilia: From Pathophysiology to Novel Therapies
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 July 2025 | Viewed by 1398
Special Issue Editor
2. Medical Doctor of the Hemophilia Treatment and Thrombosis Center, Changhua Christian Hospital, Changhua, Taipei 100, Taiwan
3. Department of Laboratory Medicine, National Taiwan University Hospital, Taipei 100, Taiwan
Interests: hemophilia; de novo variant of hemophilia and vonWillebrand disease; rare bleeding disorders; thrombosis; general hematology
Special Issue Information
Dear Colleagues,
Hemophilia is the most common X-linked congenital bleeding disorder in humans, caused by the deficiency or dysfunction of factor VIII or factor IX. The mainstay of treatment and current standard of care for hemophilia is regular prophylaxis with the administration of factor VIII/IX, mimics of clotting factors, and coagulation rebalancing agent; gene therapy is also used. We notice that most authors, physicians, and scientists devote themselves to clinical trials of these new therapeutic agents. Very few physicians are interested in and pay attention to how these new agents are created; the pathogenesis of hemophilia is even less studied. However, the latter is more fundamental and will be more instructive to young researchers, although treatments for hemophilia and the achievement of better quality of life are important. We would like to invite and encourage researchers to submit articles focusing on the development of novel therapies in hemophilia, the evolution from basic science to clinical translation, and molecular studies on the pathogenesis of hemophilia.
Prof. Dr. Mingching Shen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hemophilia
- novel therapy in hemophilia
- ultra-long half life clotting factor
- clotting factor mimics
- coagulation rebalancing agent
- gene therapy
- pathogenesis of hemophilia
- molecular biology of hemophilia
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
